Product Details
| Product Name:
SMER18 |
CAS No.:
944153-47-3 |
| Purity:
97.27% |
Supply Ability:
10g |
| Release date:
2024/11/19 |
Product Introduction
Bioactivity
| Name | SMER18 |
| Description | SMER18 is a small molecule enhancer of rapamycin, functioning as an mTOR-independent autophagy inducer. |
| In vitro | SMER18 is a small molecule enhancer of rapamycin that functions as an mTOR-independent autophagy inducer, capable of enhancing the clearance of autophagy substrates such as mutant htt (related to Huntington's disease) and A53T α-synuclein (associated with familial Parkinson's disease)[1]. |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 80 mg/mL (278.03 mM), Sonication is recommended.
|
| Keywords | SMER18 |
| Inhibitors Related | Stavudine | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Taurine | Curcumin | Oxyresveratrol | Paeonol | Naringin | Gefitinib |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:313526-24-8
$39.00 / 2mg
-
CAS:5714-00-1
$35.00 / 2mg
-
CAS:70831-56-0
$54.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States